Skip to main content
SpringerLink
Log in
Book cover

Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy pp 1–12Cite as

Platinum DNA Chemistry

  • Chapter

Abstract

This article delineates the chemistry of platinum antitumor drugs and related compounds with DNA. The evidence that DNA is primary target for cisplatin has been presented in detail elsewhere.1 Displayed in Figure 1 are structural representations of the platinum complexes to be discussed. Cisplatin and carboplatin are the only two currently approved for use clinically. They follow the classical structure-function relationships,2 being able to form cross-links at two cis positions in their coordination spheres, in contrast to the monofunctional complexes [Pt(dien)Cl]+ and [Pt(NH3)3Cl]+, and the bifunctional trans-[Pt(NH3)2Cl2] analogue. Two promising candidates for clinical trials are included, “triamine” complexes [Pt(NH3)2(4-X-py)Cl]+ (X = Me, Br) which violate two of the classical rules in being cationic and monofunctional,3 and a complex, cis-[Pt(NH3)(C6H11NH2)Cl2], that is a likely metabolite of a new class of orally active antitumor platinum(IV) compounds.4 The other compounds all have the ability to bind to DNA in whole or in part by intercalation. Since some of the compounds used in combination chemotherapy with cisplatin are intercalators, bleomycin being one example, it is important to understand their ternary interactions with DNA. Only the results of experiments carried out in vitro are included in the discussion, although we caution that there will be some differences from the reactions that take place in living cells.5

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. A. L. Pinto and S. J. Lippard, Binding of the antitumor drug cis-diamminedichloroplatinum(II) (cisplatin) to DNA, Biochim. Biophys. Acta 780:167 (1985).

    PubMed  CAS  Google Scholar 

  2. M. J. Cleare and J.D. Hoeschele, Antitumor activity of group VIII transition metal complexes. I. Platinum(II) complexes, Bioinorg. Chem., 2: 187 (1973).

    Article  CAS  Google Scholar 

  3. L. S. Hollis, A. R. Amundsen, and E. W. Stern, Chemical and biological properties of a new series of cis-diammineplatinum(II) antitumor agents containing three nitrogen donors: cis-[Pt(NH3)2(N-donor) Cl]+, J. Med. Chem., 32:128 (1989).

    Article  PubMed  CAS  Google Scholar 

  4. C. M. Giandomenico, M. J. Abrams, B. A. Murrer, and J. F. Vollano, Synthesis and reactions of a new class of orally active platinum(IV) antitumor complexes, this volume.

    Google Scholar 

  5. S. K. Mauldin, G. Gibbons, S. D. Wyrick, and S. G. Chaney, Intracellular biotransformations of platinum compounds with the 1,2-diaminocyclohexane carrier ligand in the L1210 cell line, Cancer Research, 48: 5136 (1988).

    PubMed  CAS  Google Scholar 

  6. C. A. Lepre and S. J. Lippard, Interaction of platinum antitumor compounds with DNA, Nucl. Acids Res. and Mol. Biol., 4:9 (1990).

    Article  CAS  Google Scholar 

  7. S. L. Bruhn, J. H. Toney, and S. J. Lippard, Biological Processing of DNA Modified by Platinum Compounds, Prog. Inorg. Chem., 38:477 (1990).

    Article  CAS  Google Scholar 

  8. W. I. Sundquist, D. P. Bancroft, L. Chassot, and S. J. Lippard, DNA promotes the reaction of cis-diamminedichloroplatinum(II) with the exocyclic amino groups of ethidium bromide, J. Am. Chem. Soc., 112:6960 (1990).

    Article  Google Scholar 

  9. D. P. Bancroft, C. A. Lepre, and S. J. Lippard, 195Pt NMR kinetic and mechanistic studies of cis-and trans-diamminedichloroplatinum(II) binding to DNA, J. Am. Chem. Soc., 112:6960 (1990).

    Article  Google Scholar 

  10. K. M. Comess, C. E. Costello, and S. J. Lippard, Identification and characterization of a novel linkage isomerization in the reaction of trans-diamminedichloroplatinum(II) with 5′-d(TCTACGCGTTCT), Biochemistry, 29:2102 (1990).

    Article  PubMed  CAS  Google Scholar 

  11. K. M. Comess, unpublished results.

    Google Scholar 

  12. S. E. Sherman and S. J. Lippard, Structural aspects of platinum anticancer drug interactions with DNA, Chem. Rev., 87:1153 (1987).

    Article  CAS  Google Scholar 

  13. S. E. Sherman, D. Gibson, A. H.-J. Wang, and S. J. Lippard, Crystal and molecular structure of cis-[Pt(NH3)2d(pGpG)], the principal adduct formed by cis-diamminedichloroplatinum(II) with DNA. J. Am. Chem. Soc.. 110:7368, 1988.

    Article  CAS  Google Scholar 

  14. S. F. Bellon and S. J. Lippard, unpublished results.

    Google Scholar 

  15. With D. Patel and colleagues, Columbia University.

    Google Scholar 

  16. J. F. Hartwig and S. J. Lippard, unpublished results.

    Google Scholar 

  17. C. A. Lepre, K. G. Strothkamp, and S. J. Lippard, Synthesis and 1H NMR spectroscopic characterization of trans-[Pt(NH3)2d(ApGpGpCpCpT)-N7-A(1),N7-G(3)], Biochemistry, 26:5651 (1987).

    Article  PubMed  CAS  Google Scholar 

  18. J. L. van der Veer, G. J. Ligtvoet, H. van den Elst, and J. Reedijk, trans-Diamminedichloroplatinumt(II) can chelate d(GpTpG) via both guanines in a similar fashion as the cis isomer, J. Am. Chem. Soc., 108:3860 (1986).

    Article  Google Scholar 

  19. L. S. Hollis, W. I. Sundquist, J. N. Burstyn, W. J. Heiger-Bernays, S. F. Bellon, K. J. Ahmed. A. R. Amundsen, E. W. Stern and S. J. Lippard, Mechanistic studies of a novel class of trisubstituted platinum(II) antitumor agents, Cancer Research, in press.

    Google Scholar 

  20. E. L. M. Lempers, M. J. Bloemink, J. Brouwer, Y. Kidani, and J. Reedijk, The new antitumor compound, cis-[Pt(NH3)2(4-methylpyridine)Cl]Cl, does not form N7,N7-d(GpG) chelates with DNA. An unexpected preference for platinum binding at the 5′G in d(GpG). J. Inorg. Biochem., 40: 23 (1990).

    Article  PubMed  CAS  Google Scholar 

  21. S. J. Lippard, H. M. Ushay, C. M. Merkel, and M. C. Poirier, Use of antibodies to probe the stereochemistry of antitumor platinum drug binding to DNA, Biochemistry, 22:5165 (1983).

    Article  CAS  Google Scholar 

  22. W. I. Sundquist, S. J. Lippard, and B. D. Stollar. Monoclonal antibodies to DNA modified with cis-or trans-diamminedichloroplatinum(II). Proc. Natl. Acad. Sci. U.S.A.. 84:8225, 1987.

    Article  PubMed  CAS  Google Scholar 

  23. J. A. Rice, D. M. Pinto, A. L. Pinto, and S. J. Lippard, The major adduct of the antitumor drug cis-diamminedichloroplatinum(II) with DNA bends the duplex by ~40° toward the major groove, Proc Natl. Acad. Sci. U.S.A., 85:4158 (1988).

    Article  PubMed  CAS  Google Scholar 

  24. S. F. Bellon and S. J. Lippard, Bending studies of DNA site-specifically modified by cisplatin, trans-diamminedichloroplatinum(II), and cis-[Pt(NH3)2(N3-cytosine)Cl]+, Biophys. Chem., 35:179 (1990).

    Article  PubMed  CAS  Google Scholar 

  25. S. F. Bellon and S. J. Lippard, unpublished results.

    Google Scholar 

  26. A. L. Pinto, L. J. Naser, J. M. Essigmann, and S. J. Lippard, Site-specifically platinated DNA, a new probe of the biological activity of platinum anticancer drugs. J. Am. Chem. Soc. 108:7405 (1986).

    Article  CAS  Google Scholar 

  27. M. Anin and M. Leng, Distortions induced in double-stranded oligonucleotides by the binding of cis-12 or trans-diammine-dichloroplatinum(II) to the d(GTG) sequence, Nucleic Acids Res., 18:4395 (1990).

    Article  PubMed  CAS  Google Scholar 

  28. K. W. Jennette, S. J. Lippard, G. A Vassiliades, and W. R. Bauer, Metallointercalation reagents. 2-Hydroxyethanethiolate(2,2′,2″-terpyridine)platinum(II) monocation binds strongly to DNA by intercalation, Proc. Natl. Acad. Sci. U.S.A., 71:3839 (1974).

    Article  PubMed  CAS  Google Scholar 

  29. M. Howe-Grant, K. Wu, W. R. Bauer, and S. J. Lippard, Binding of platinum and palladium metallointercalation reagents and antitumor drugs to closed and open DNAs, Biochemistry, 15:4339 (1976).

    Article  PubMed  CAS  Google Scholar 

  30. A. H. J. Wang, J. Nathans, G. van der Marel, J. H. van Boom, and A. Rich, Molecular structure of a double helical DNA fragment-intercalator complex: deoxy CpG and a terpyridine platinum compound, Nature, 276:471 (1978).

    Article  PubMed  CAS  Google Scholar 

  31. J-P. Macquet and J-L. Butour, DNA-platinun interactions, J. Clin. Hematol. Oncol., 7:469 (1977).

    CAS  Google Scholar 

  32. T. D. Tullius and S. J. Lippard, Ethidium bromide changes the nuclease-sensitive DNA binding sites of the antitumor drug cis-diamminedichloroplatinum(II), Proc. Natl. Acad. Sci. U.S.A., 79:3489 (1982).

    Article  PubMed  CAS  Google Scholar 

  33. C. M. Merkel and S. J. Lippard, Ethidium bromide alters the binding mode of cis-diamminedichloroplatinum(II) to pBR322 DNA, Cold Spring Harbor Symp.Quant. Biol. 47:355 (1983).

    Article  PubMed  Google Scholar 

  34. J-M. Malinge and M. Leng, Reaction of nucleic acids and cis-diamminedichloroplatinum(II) in the presence of intercalating agents, Proc. Natl. Acad. Sci. U.S.A., 83:6317 (1986).

    Article  PubMed  CAS  Google Scholar 

  35. D. P. Bancroft, W. I. Sundquist, L. Chassot, and S. J. Lippard, unpublished results.

    Google Scholar 

  36. B. E. Bowler, K. J. Ahmed, W. I. Sundquist, L. S. Hollis, E. E. Whang, and S. J. Lippard, Synthesis, characterization, and DNA-binding properties of (1,2-diaminoethane)platinum(II) complexes linked to the DNA intercalator acridine orange by trimethylene and hexamethylene chains, J. Am. Chem. Soc. 111:1299 (1989).

    Article  CAS  Google Scholar 

  37. B. A. Donahue, M. Augot, S. F. Bellon, D. K. Treiber, J. H. Toney, S. J. Lippard, and J. M. Essigmann, Characterization of a DNA damage-recognition protein from mammalian cells that bind specifically to intrastrand d(GpG) and d(ApG) DNA adducts of the anticancer drug cisplatin, Biochemistry, 29:5872 (1990).

    Article  PubMed  CAS  Google Scholar 

  38. J. H. Toney, B. A. Donahue, P. J. Kellett, S. L. Bruhn, J. M. Essigmann, and S. J. Lippard, Isolation of cDNAs encoding a human protein that binds selectively to DNA modified by the antitumor drug cis-diamminedichloroplatinum(II), Proc. Natl. Acad. Sci. U.S.A., 86:8328 (1989).

    Article  PubMed  CAS  Google Scholar 

  39. B. A. Donahue, S. L. Bellon, S. J. Lippard, and J. M. Essigmann, this volume.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Chemistry, Massachusetts Institute of Chemistry, Cambridge, Massachusetts, 02139, USA

    Stephen J. Lippard

Authors
  1. Stephen J. Lippard
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of California, San Diego, La Jolla, California, USA

    Stephen B. Howell

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer Science+Business Media New York

About this chapter

Cite this chapter

Lippard, S.J. (1991). Platinum DNA Chemistry. In: Howell, S.B. (eds) Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0738-7_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-0738-7_1

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-0740-0

  • Online ISBN: 978-1-4899-0738-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation